AngioDynamics, Inc. Stock Prediction
AI-powered sentiment analysis and prediction trends for ANGO, updated each market day.
ANGO AI Sentiment
AI sees no strong directional signal for AngioDynamics, Inc. stock over the next 10 market days.
Prediction date: Sept. 17, 2026
Exact scores are in the SharePreds app
The precise prediction score for this stock, with buy and sell targets and a stop loss, updated every market day.
About AngioDynamics, Inc.
AngioDynamics Inc is a dynamic, diversified medical technology company committed to expanding treatment options and improving patient outcomes and quality of life by designing, manufacturing, and selling products and technologies that aid clinicians in the treatment of patients with cardiovascular disease and cancer diagnoses. The company's execution plan is built on R&D, clinical and regulatory pathway expansion, and customer-centric sales performance. The company's product offerings fall within two segments, Med Tech and Med Device. Med Tech includes Auryon and Thrombectomy, while Med Device has Peripheral Products (Interventional Devices), Ports, and Microwave Ablation. Geographically operates in the USA and Other countries; maximum revenue from the USA.
Sector
Exchange
Market Cap
$635,278,818
Cap Tier
Employees
632
Headquarters
LATHAM, NY
Listed Since
May 27, 2004
Website
ANGO Sentiment Trend: Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
ANGO Volatility
AngioDynamics, Inc. has shown moderate price volatility over the last 5 trading days. Moderate volatility indicates normal market activity with typical price fluctuations.
